Ascendis Pharma A ASND
NASDAQ ASND
$227.87 +0.56 (+0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Amortizatization of Intangibles (2021 - 2025)

Updated

Ascendis Pharma A (ASND) reported Amortizatization of Intangibles of $150,162 for the quarter ended Dec 31, 2025, up 18.1% from $127,163 a year earlier and up 4.4% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Ascendis Pharma A posted Amortizatization of Intangibles of $553,607, up 9.5% from the prior year.

  • Amortizatization of Intangibles has a four-year compound annual growth rate of 2.1% (years ended Dec 2021 to Dec 2025).
  • By year, Amortizatization of Intangibles came in at $505,452 in the year ended Dec 31, 2024 (-3.3%), $522,470 in the year ended Dec 31, 2023 (+11.6%), $467,956 in the year ended Dec 31, 2022 (-8.1%) and $509,067 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 ranks as the highest quarterly Amortizatization of Intangibles since the quarter ended Dec 31, 2023.
  • Year over year, Amortizatization of Intangibles has now increased in each of the last three quarters, with growth averaging 4.0% over the last eight quarters.
  • The high point for year-over-year Amortizatization of Intangibles in five years was the quarter ended Dec 31, 2023 (growth of 42.5%); the low point was the quarter ended Dec 31, 2024 (a decline of 21.2%).
  • Per Business Quant data, the three quarters before the quarter ended Dec 31, 2025 came in at $143,794 (quarter ended Sep 30, 2025), $134,703 (quarter ended Jun 30, 2025) and $125,174 (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 150,161.61
Sep 30, 2025 143,793.78
Jun 30, 2025 134,703.20
Mar 31, 2025 125,174.25
Dec 31, 2024 127,162.85
Sep 30, 2024 126,295.24
Jun 30, 2024 123,842.07
Mar 31, 2024 128,190.69
Dec 31, 2023 161,390.99
Sep 30, 2023 120,833.54
Jun 30, 2023 120,870.61
Mar 31, 2023 119,140.94
Dec 31, 2022 113,247.46
Sep 30, 2022 111,918.45
Jun 30, 2022 118,443.29
Mar 31, 2022 124,579.49
Dec 31, 2021 128,124.75
Sep 30, 2021 130,900.89
Jun 30, 2021 133,674.13
Mar 31, 2021 133,892.21
API Access

Ascendis Pharma A Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=ASND&period=max&api_key=YOUR_API_KEY